Locations

San Diego County

3020 Children's Way
MC 5103
San Diego, CA 92123

Specialty

Endocrinology/Diabetes

Organization

Rady Children's Specialists of San Diego

Medical Group / IPA

CPMG/RCHN/RCSSD

Other Languages

Portuguese, Spanish

Medical School

Universidade Federal Do Parana

Residency

University of California San Diego-Hospital

Fellowship

University of California San Diego-Hospital

Board Certifications

Endocrinology/Diabetes, Pediatrics

Gender

F

Bio

Dr. Demeterco-Berggren, MD, PhD, is a Clinical Professor of Pediatrics at the University of California, San Diego (UCSD) and a leading pediatric endocrinologist at Rady Children’s Hospital-San Diego (RCHSD), where she directs the Diabetes Program.

She completed her pediatric residence and pediatric endocrinology fellowship training at University of California, San Diego after earning her medical degree, residency in pediatrics and endocrinology fellowship at the Federal University of Parana (UFPR) in Brazil. She also earned her PhD in Endocrinology and Metabolism at the Federal University of São Paulo (UNIFESP) and conducted her postdoctoral research at UCSD in pancreatic beta-cell biology and developmental therapeutics for Type 1 Diabetes (T1D).

Dr. Demeterco-Berggren brings a unique dual perspective as both a clinician and scientist to her work in type 1 diabetes (T1D), with a focus on advancing emerging technologies and therapies, promoting health equity, and improving clinical outcomes for pediatric and adolescent populations. Her contributions to the field have been recognized with the 2024 CARES Award for Physician Excellence from Rady Children’s Hospital, underscoring her leadership and commitment to translational research and patient-centered care.

She serves as the Principal Investigator for the T1D Exchange Quality Improvement Collaborative (T1DX-QI) at Rady Children’s and is the National Co-Chair of its Collaborative Leadership Committee. A nationally recognized leader in diabetes implementation science, Dr. Demeterco-Berggren contributes to both national and international Quality Improvement advisory boards in diabetes.

Her work has been recognized with numerous honors, including:

  • 2024 Outstanding Pediatric Principal Investigator, T1DX-QI Collaborative
  • 2021 Quality Improvement Exemplar, American Board of Pediatrics (ABP)
  • 2021 Roger Roux Award, for Most Impactful QI Project at Rady Children’s Hospital
  • 2020 Outstanding New Team Award, T1DX-QI Collaborative

Through her clinical care, research, and leadership, Dr. Demeterco-Berggren continues to drive innovation and meaningful improvements in diabetes care for youth. She is also a dedicated mentor to medical students, residents, fellows, and junior faculty.

Outside of her professional work, she enjoys cooking and traveling with her husband and son.

Publications

Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016–2022) from the T1D Exchange Quality Improvement Collaborative.
Ebekozien O, Mungmode A, Sanchez J, Rompicherla S, Demeterco-Berggren C, Weinstock RS, Jacobsen LM, Davis G, McKee A, Akturk HK, Maahs DM, Kamboj MK

Current Practices in Operationalizing and Addressing Racial Equity in the Provision of Type 1 Diabetes Care: Insights from the Type 1 Diabetes Exchange Quality Improvement Collaborative Health Equity Advancement Lab.
Addala A, Mungmode A, Ospelt E, Sanchez JE, Malik F, Demeterco-Berggren C, Butler A, Edwards C, Manukyan M, Ochoa-Maya M, Zupa M, Ebekozien O

Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection.
Tallon EM, Ebekozien O, Sanchez J, Staggs VS, Ferro D, McDonough R, Demeterco-Berggren C, Polsky S, Gomez P, Patel N, Prahalad P, Odugbesan O, Mathias P, Lee JM, Smith C, Shyu CR, Clements MA

Making Diabetes Electronic Medical Record Data Actionable: Promoting Benchmarking and Population Health Improvement Using the T1D Exchange Quality Improvement Portal.
Ann Mungmode, Nudrat Noor, Ruth S. Weinstock, Roberto Izquierdo, Justin A. Indyk, Daniel J. DeSalvo, Sarah Corathers, Carla Demeterco-Berggren, Susan Hsieh, Laura M. Jacobsen, Allison Mekhoubad, Halis Kaan Akturk, Anton Wirsch, Mary Lauren Scott, Lily C. Chao, Brian Miyazaki, Faisal S. Malik, Osagie Ebekozien, Mark Clements, G. Todd Alonso

Factors Associated With Achieving Target A1C in Children and Adolescents With Type 1 Diabetes: Findings From the T1D Exchange Quality Improvement Collaborative.
Demeterco-Berggren C, Ebekozien O, Noor N, Rompicherla S, Majidi S, Jones NY, McDonough R, Odugbesan O, Kim A, Izquierdo R, Kamboj MK, Jacobsen LM

Hybrid Closed-Loop Systems and Glycemic Outcomes in Children and Adults With Type 1 Diabetes: Real-World Evidence From a U.S.-Based Multicenter Collaborative.
Noor N, Kamboj MK, Triolo T, Polsky S, McDonough RJ, Demeterco-Berggren C, Jacobsen L, Sonabend R, Ebekozien O, DeSalvo DJ

Trends in Type 1 Diabetic Ketoacidosis During COVID-19 Surges at 7 US Centers: Highest Burden on non-Hispanic Black Patients.
Lavik AR, Ebekozien O, Noor N, Alonso GT, Polsky S, Blackman SM, Chen J, Corathers SD, Demeterco-Berggren C, Gallagher MP, Greenfield M, Garrity A, Rompicherla S, Rapaport R, Yayah Jones NH

Differences in COVID-19 Outcomes Among Patients With Type 1 Diabetes: First vs Later Surges.
Mary Pat Gallagher, Saketh Rompicherla, Osagie Ebekozien, Meredith Wilkes, Zoltan Antal, Alexis Jamie Feuer, Nicole Rioles, Nudrat Noor, Liana Gabriel, Grenye O’Malley, Lauren Golden, G. Todd Alonso, Emma Ospelt, Ori Odugbesan, Sarah K. Lyons, Ann Mungmode, Priya Prahalad, Mark Clements, Anna Neyman, Carla Demeterco-Berggren, Robert Rapaport

Response to Letter to the Editor from Justin M. Gregory: "Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study".
Demeterco-Berggren C, Ebekozien O, Levy CJ, Maahs DM

Increase in newly diagnosed type 1 diabetes in youth during the COVID-19 pandemic in the United States: A multi-center analysis.
Wolf RM, Noor N, Izquierdo R, Jett D, Rewers A, Majidi S, Sheanon N, Breidbart E, Demeterco-Berggren C, Lee JM, Kamboj MK, Ebekozien O

Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study.
Demeterco-Berggren C, Ebekozien O, Rompicherla S, Jacobsen L, Accacha S, Gallagher MP, Todd Alonso G, Seyoum B, Vendrame F, Haw JS, Basina M, Levy CJ, Maahs DM

Inequities in Health Outcomes in Children and Adults With Type 1 Diabetes: Data From the T1D Exchange Quality Improvement Collaborative.
Majidi S, Ebekozien O, Noor N, Lyons SK, McDonough R, Gandhi K, Izquierdo R, Demeterco-Berggren C, Polsky S, Basina M, Desimone M, Thomas I, Rioles N, Jimenez-Vega J, Malik FS, Miyazaki B, Albanese-O'Neill A, Jones NY, T1D Exchange Quality Improvement Collaborative Study Group

Quality Improvement in Diabetes Care: A Review of Initiatives and Outcomes in the T1D Exchange Quality Improvement Collaborative.
Ginnard OZB, Alonso GT, Corathers SD, Demeterco-Berggren C, Golden LH, Miyazaki BT, Nelson G, Ospelt E, Ebekozien O, Lee JM, Obrynba KS, DeSalvo DJ, T1D Exchange Quality Improvement Collaborative Study Group

Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic.
Lee JM, Carlson E, Albanese-O'Neill A, Demeterco-Berggren C, Corathers SD, Vendrame F, Weinstock RS, Prahalad P, Alonso GT, Kamboj M, DeSalvo DJ, Malik FS, Izquierdo R, Ebekozien O

Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: Data from a multi-site surveillance registry.
Beliard K, Ebekozien O, Demeterco-Berggren C, Alonso GT, Gallagher MP, Clements M, Rapaport R

Continuous glucose monitoring in a cystic fibrosis patient to predict pulmonary exacerbation?
Inman TB, Proudfoot JA, Lim M, Demeterco-Berggren C

Thyrotoxic, hypokalemic periodic paralysis (THPP) in adolescents.
Al-Zubeidi H, Demeterco C, Jones KL

Unawareness of the effects of soy intake on the management of congenital hypothyroidism.
Fruzza AG, Demeterco-Berggren C, Jones KL

Adult human beta-cell neogenesis?
Demeterco C, Hao E, Lee SH, Itkin-Ansari P, Levine F

Islet specific Wnt activation in human type II diabetes.
Lee SH, Demeterco C, Geron I, Abrahamsson A, Levine F, Itkin-Ansari P

NeuroD1 in the endocrine pancreas: localization and dual function as an activator and repressor.
Itkin-Ansari P, Marcora E, Geron I, Tyrberg B, Demeterco C, Hao E, Padilla C, Ratineau C, Leiter A, Lee JE, Levine F

Cell-based therapies for diabetes: progress towards a transplantable human beta cell line.
Itkin-Ansari P, Geron I, Hao E, Demeterco C, Tyrberg B, Levine F

c-Myc controls proliferation versus differentiation in human pancreatic endocrine cells.
Demeterco C, Itkin-Ansari P, Tyrberg B, Ford LP, Jarvis RA, Levine F

Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo.
de la Tour D, Halvorsen T, Demeterco C, Tyrberg B, Itkin-Ansari P, Loy M, Yoo SJ, Hao E, Bossie S, Levine F

Gene therapy for diabetes.
Demeterco C, Levine F

A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth.
Demeterco C, Beattie GM, Dib SA, Lopez AD, Hayek A

PDX-1 and cell-cell contact act in synergy to promote delta-cell development in a human pancreatic endocrine precursor cell line.
Itkin-Ansari P, Demeterco C, Bossie S, de la Tour DD, Beattie GM, Movassat J, Mally MI, Hayek A, Levine F

Rady Children's updates the Doctor Finder annually. We are not responsible for omissions or errors. Prior to making an appointment, please be sure to check with your health plan to confirm coverage. If you see an error or omission on a physician's profile page, please contact us at refsvc@rchsd.org.